Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novamed is an Israeli life sciences company specializing in the development and manufacturing of innovative diagnostic systems and products. Founded in 1995 and headquartered in Jerusalem, the company provides a wide range of in-vitro diagnostic (IVD) solutions, including rapid tests for infectious diseases, microbiology culture media, and clinical chemistry reagents. Novamed is particularly recognized for its advanced diagnostic kits used in point-of-care settings and clinical laboratories worldwide, such as its proprietary Strep A and pregnancy tests. In 2021, Novamed was acquired by Scienion, a subsidiary of the BICO Group, to integrate its diagnostic manufacturing expertise into BICO's broader bio-convergence portfolio. This acquisition has enabled Novamed to expand its global reach and leverage Scienion's precision dispensing technologies for next-generation diagnostic development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novamed Laboratories.